Sean Mark Dalziel,Naveen Bejugam,Nazila Habibizad,Ali Komeyli,DeMei Leung
申请号：
US15782381
公开号：
US20180125789A1
申请日:
2017.10.12
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Provided herein are high strength/high drug load tablets comprising 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde (“Compound 1”), dispersible tablets comprising Compound 1, processes of manufacturing such tablets, and methods for treating patients with the tablets. Compound 1 is useful for treating hematological disorders such as sickle cell disease, pulmonary disease such as idiopathic pulmonary fibrosis, and hypoxia and hypoxemia conditions.
